[A complex vaccine in the prevention of staphylococcal, Pseudomonas aeruginosa and Proteus infections in esophageal cancer patients].
An analysis of clinico-immunological data has demonstrated a considerable decline in non-specific and specific defences against such major factors of hospital infection in esophageal cancer patients as staphylococcal, blue pus and Proteus bacilli. Immunization with a complex vaccine including concentrated staphylococcal anatoxin, blue pus and Proteus vaccines was shown to stimulate the said factors of anti-infectious immunity and to be followed by a 4.7-fold decrease in the incidence of postoperative pyo-inflammatory complications. The said vaccine may be recommended for prevention of infectious complications in cancer patients since its administration is followed by a low-level reaction matched by a marked increase in immunologic vigor.
D000917:Antibody Formation; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D004938:Esophageal Neoplasms / Q000150:complications* / Q000276:immunology / Q000382:microbiology; D006801:Humans; D007114:Immunization; D011183:Postoperative Complications / Q000517:prevention & control*; D011300:Preoperative Care; D011511:Proteus / Q000276:immunology; D011512:Proteus Infections / Q000517:prevention & control*; D011549:Pseudomonas / Q000276:immunology; D011552:Pseudomonas Infections / Q000517:prevention & control*; D013203:Staphylococcal Infections / Q000517:prevention & control*; D013208:Staphylococcal Toxoid / Q000627:therapeutic use
D001428:Bacterial Vaccines; D004338:Drug Combinations; D013208:Staphylococcal Toxoid
Kompleksnaia vaktsina v profilaktike stafilokokkovoĭ, sinegnoĭnoĭ i proteĭnoĭ infektsiĭ u bol'nykh rakom pishchevoda.